A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment
Clinical trial NCT04059081 · UNKNOWN
Trial details
- NCT number
- NCT04059081
- Sponsor
- Deok-Hwan Yang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-09
- Primary completion
- 2022-07-08
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.